COSMO Pharmaceuticals SA
Save
1.01B
Market cap
45.75x
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Cosmo Pharmaceuticals N. V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and Methylene Blue MMX, diagnostic drug to enhance pre-cancerous and cancerous detection of colorectal lesions during colonoscopy.
Similar securities
Based on sector and market capitalization
Report issue